Discontinued — last reported Q3 '22
Investing
Acquisitions
Gilead Sciences Acquisitions increased by 264.7% to $609.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 712.0%, from $75.00M to $609.00M. Over 4 years (FY 2021 to FY 2025), Acquisitions shows a downward trend with a -6.5% CAGR.
Analysis
StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ4 2013
Last reportedQ3 2022
How to read this metric
High spending indicates an aggressive growth strategy, while low spending may indicate a focus on organic growth or debt reduction.
Detailed definition
This represents the net cash outflow for the purchase of other businesses or strategic assets, adjusted for any cash acq...
Peer comparison
Highly variable; pharmaceutical companies frequently use M&A to offset patent cliffs and expand therapeutic portfolios.
Metric ID:
cf_acquisitionsHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $92.00M | $54.00M | $1.00M | $30.00M | $1.10B | $448.00M | $218.00M | $551.00M | $243.00M | $79.00M | $279.00M | $4.04B | $152.00M | $570.00M | $75.00M | $273.00M | $21.00M | $167.00M | $609.00M |
| QoQ Change | — | -41.3% | -98.1% | >999% | >999% | -59.3% | -51.3% | +152.8% | -55.9% | -67.5% | +253.2% | >999% | -96.2% | +275.0% | -86.8% | +264.0% | -92.3% | +695.2% | +264.7% |
| YoY Change | — | — | — | — | >999% | +729.6% | >999% | >999% | -77.9% | -82.4% | +28.0% | +633.8% | -37.4% | +621.5% | -73.1% | -93.2% | -86.2% | -70.7% | +712.0% |
Range$1.00M – $4.04B
CAGR+52.2%
Avg YoY Growth>999%
Median YoY Growth+28.0%
Current Streak2 quarters growth
Acquisitions at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's acquisitions?
- Gilead Sciences (GILD) reported acquisitions of $609.00M in Q4 2025.
- How has Gilead Sciences's acquisitions changed year-over-year?
- Gilead Sciences's acquisitions increased by 712.0% year-over-year, from $75.00M to $609.00M.
- What is the long-term trend for Gilead Sciences's acquisitions?
- Over 4 years (2021 to 2025), Gilead Sciences's acquisitions has grown at a -6.5% compound annual growth rate (CAGR), from $1.40B to $1.07B.
- What does acquisitions mean?
- Cash spent to acquire other companies or businesses, net of cash received in the deal.